We are live on ! Find out more
ROTUOC

Regents of the University of California Portfolio holdings

AUM $4.36B
1-Year Est. Return 33.89%
This Fund
S&P 500
This Quarter Est. Return
-4.13%
1 Year Est. Return
+33.89%
3 Year Est. Return
+86.09%
5 Year Est. Return
+63.96%
10 Year Est. Return
+870.04%
AUM
$714M
AUM Growth
-$136M
Cap. Flow
-$88.9M
Cap. Flow %
-12.46%
Top 10 Hldgs %
92.55%
Holding
43
New
6
Increased
1
Reduced
5
Closed
3

Top Buys

Rank Stock Value
1
U icon
Unity
U
+$16.1M
2
ABNB icon
Airbnb
ABNB
+$5.34M
3
QS icon
QuantumScape Corp
QS
+$4.08M
4
ORIC icon
Oric Pharmaceuticals
ORIC
+$2.31M
5
CBUS icon
Cibus
CBUS
+$1.46M

Sector Composition

Rank Sector Weight
1 Financials 65.53%
2 Technology 11.06%
3 Consumer Discretionary 9.37%
4 Healthcare 7.91%
5 Real Estate 2.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OBDC icon
1
Blue Owl Capital
OBDC
$5.75B
$455M 63.81%
32,157,815
-5,338,078
-14% -$76.3M
IS
2
DELISTED
ironSource Ltd.
IS
$61.9M 8.68%
8,000,000
BABA icon
3
Alibaba
BABA
$300B
$54.9M 7.7%
462,431
OPEN icon
4
Opendoor
OPEN
$3.39B
$17.9M 2.5%
1,263,050
-3,673
-0.3% -$67.9K
RAPT
5
DELISTED
RAPT Therapeutics
RAPT
$16.3M 2.28%
55,452
-20,631
-27% -$5.51M
U icon
6
Unity
U
$19.6B
$15M 2.11%
+105,117
New +$16.1M
NTLA icon
7
Intellia Therapeutics
NTLA
$1.69B
$13.2M 1.85%
111,440
EL icon
8
Estee Lauder
EL
$31.7B
$12.4M 1.73%
33,400
ARVN icon
9
Arvinas
ARVN
$580M
$7.52M 1.05%
91,576
+14,274
+18% +$1.16M
SANA icon
10
Sana Biotechnology
SANA
$1.13B
$6M 0.84%
387,508
NRIX icon
11
Nurix Therapeutics
NRIX
$2.76B
$5.91M 0.83%
204,123
-367,089
-64% -$11.1M
AFRM icon
12
Affirm
AFRM
$24.6B
$5.31M 0.74%
52,842
ABNB icon
13
Airbnb
ABNB
$108B
$5.04M 0.71%
+30,302
New +$5.34M
QS icon
14
QuantumScape Corp
QS
$3.92B
$3.3M 0.46%
+148,850
New +$4.08M
APD icon
15
Air Products & Chemicals
APD
$67.7B
$3.1M 0.43%
10,200
MDY icon
16
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.2B
$2.9M 0.41%
5,600
SPGI icon
17
S&P Global
SPGI
$121B
$2.83M 0.4%
6,000
BRK.B icon
18
Berkshire Hathaway Class B
BRK.B
$1.09T
$2.4M 0.34%
8,043
ORIC icon
19
Oric Pharmaceuticals
ORIC
$1.43B
$2.18M 0.31%
+148,322
New +$2.31M
XOM icon
20
ExxonMobil
XOM
$657B
$2.06M 0.29%
33,600
PDD icon
21
Pinduoduo
PDD
$127B
$1.97M 0.28%
33,734
-16,848
-33% -$1.33M
MRK icon
22
Merck
MRK
$328B
$1.66M 0.23%
21,600
DASH icon
23
DoorDash
DASH
$92.1B
$1.65M 0.23%
11,089
PFE icon
24
Pfizer
PFE
$150B
$1.63M 0.23%
27,645
TXN icon
25
Texas Instruments
TXN
$253B
$1.23M 0.17%
6,500

Similar funds

Regents of the University of California's Q4 2021 Portfolio in Review

As of Q4 2021, Regents of the University of California held 43 positions worth $714M, down 16% from $849M the previous quarter. Its ten largest holdings account for 93% of the portfolio.

Regents of the University of California withdrew a net $88.9M in Q4 2021, closing 3 positions and reducing 5 holdings. Its most notable exit was Upstart Holdings, an estimated $24.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 66% of assets, down from 67% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Regents of the University of California opened a new position in Unity worth $15M.

  • Regents of the University of California's largest Q4 2021 buy was Unity: 105,117 shares worth $15M.
  • Regents of the University of California added most to Arvinas in Q4 2021, an estimated $1.16M increase.
  • Regents of the University of California's biggest Q4 2021 reduction was Blue Owl Capital, cutting an estimated $76.3M.
  • Regents of the University of California fully exited Upstart Holdings in Q4 2021, selling an estimated $24.8M.
  • Regents of the University of California's ten largest holdings make up 93% of its $714M portfolio in Q4 2021.
  • Regents of the University of California opened 6 new positions and closed 3 in Q4 2021.
  • Regents of the University of California's portfolio value fell 16% quarter-over-quarter to $714M.

Based on Regents of the University of California's 13F filing for Q4 2021, filed 24 Jan 2022.